Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stents to Treat De Novo Coronary Lesions

NCT00301522 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

1108

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Stenosis

Interventions

DEVICE: TAXUS Paclitaxel-Eluting Coronary Stent, Slow-Formulation
DEVICE: Express2

Sponsor

Boston Scientific Corporation